B-type natriuretic peptide and severe heart failure at baseline predict overall mortality in incident dialysis

M Koch1, R Trapp, M Kohnle

  • 1Center of Nephrology, Mettmann, Heinrich Heine University Düsseldorf, Germany. dialyse-mettmann.de

Clinical Nephrology
|December 31, 2009
PubMed

Insights

Higher baseline B-type natriuretic peptide (BNP) levels predict death in incident hemodialysis patients. However, severe heart failure is a stronger predictor of overall mortality than BNP in this population.

Area of Science:

  • Nephrology
  • Cardiology
  • Biomarkers

Background:

  • B-type natriuretic peptide (BNP) is crucial for diagnosing and predicting cardiovascular disease.
  • Prospective data on baseline BNP and heart failure as mortality predictors in incident hemodialysis patients are limited.

Purpose of the Study:

  • To evaluate baseline BNP and heart failure as predictors of overall mortality in incident end-stage renal disease (ESRD) patients undergoing hemodialysis.
  • To investigate the independent predictive value of BNP and severe heart failure on mortality.

Main Methods:

  • An observational study included 255 ESRD patients with a median follow-up of 1.11 years.
  • Kaplan-Meier survival curves analyzed mortality rates stratified by baseline BNP levels (< 340 pg/ml vs. >= 340 pg/ml).
  • Univariate and multiple Cox regression models assessed predictors of death, including severe heart failure (New York Heart Association classification).

Main Results:

  • Higher baseline BNP concentrations were associated with significantly increased mortality.
  • Multiple Cox regression initially confirmed high BNP as an independent predictor of death.
  • However, when severe heart failure was included in the model, it emerged as a stronger predictor of overall death than BNP.

Conclusions:

  • Elevated baseline BNP levels predict mortality in incident dialysis patients.
  • Severe heart failure significantly influences the predictive impact of BNP on survival.
  • Severe heart failure may be a more potent predictor of overall mortality than BNP in this cohort.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this measurement...
Dialysis01:27

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...